These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34158840)

  • 21. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.
    Gong H; Kovar JL; Cheung L; Rosenthal EL; Olive DM
    Cancer Biol Ther; 2014 Feb; 15(2):185-93. PubMed ID: 24100437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
    Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
    J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
    Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
    Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
    Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
    Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    Folaron M; Strawbridge R; Samkoe KS; Serafini CE; Roberts DW; Davis SC
    J Neurosurg; 2019 Sep; 131(3):724-734. PubMed ID: 30192200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
    Abrigo JM; Fountain DM; Provenzale JM; Law EK; Kwong JS; Hart MG; Tam WWS
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011551. PubMed ID: 29357120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between the sodium fluorescein yellow fluorescence boundary and the actual boundary of high-grade gliomas during surgical resection.
    Chen ZB; Zhu XP; Zheng W; Xiang Y; Huang YK; Fang HJ; Deng AJ; Yi FR; Chen HW; Han DQ; Lv SQ
    Br J Neurosurg; 2024 Aug; 38(4):825-832. PubMed ID: 34542381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraoperative computed tomography, navigated ultrasound, 5-amino-levulinic acid fluorescence and neuromonitoring in brain tumor surgery: overtreatment or useful tool combination?
    Barbagallo GM; Maione M; Peschillo S; Signorelli F; Visocchi M; Sortino G; Fiumanò G; Certo F
    J Neurosurg Sci; 2024 Feb; 68(1):31-43. PubMed ID: 31298506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.
    van Keulen S; van den Berg NS; Nishio N; Birkeland A; Zhou Q; Lu G; Wang HW; Middendorf L; Forouzanfar T; Martin BA; Colevas AD; Rosenthal EL
    Oral Oncol; 2019 Jan; 88():58-65. PubMed ID: 30616798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing the Extent of Resection and Minimizing the Morbidity in Insular High-Grade Glioma Surgery by High-Field Intraoperative MRI Guidance.
    Chen LF; Yang Y; Ma XD; Yu XG; Gui QP; Xu BN; Zhou DB
    Turk Neurosurg; 2017; 27(5):696-706. PubMed ID: 27651342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood-Brain Barrier Disruption, Sodium Fluorescein, And Fluorescence-Guided Surgery Of Gliomas.
    Xiang Y; Zhu XP; Zhao JN; Huang GH; Tang JH; Chen HR; Du L; Zhang D; Tang XF; Yang H; Lv SQ
    Br J Neurosurg; 2018 Apr; 32(2):141-148. PubMed ID: 29357709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
    Nakajima H; Kotani D; Bando H; Kato T; Oki E; Shinozaki E; Sunakawa Y; Yamazaki K; Yuki S; Nakamura Y; Yamanaka T; Yoshino T; Ohta T; Taniguchi H; Kagawa Y
    BMC Cancer; 2021 Jun; 21(1):674. PubMed ID: 34098908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue.
    Li C; Mi J; Wang Y; Zhang Z; Guo X; Zhou J; Hu Z; Tian J
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):494-507. PubMed ID: 36207638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Panitumumab-IRDye800CW and 5-Aminolevulinic Acid to Provide Optical Contrast in a Model of Glioblastoma Multiforme.
    Napier TS; Udayakumar N; Jani AH; Hartman YE; Houson HA; Moore L; Amm HM; van den Berg NS; Sorace AG; Warram JM
    Mol Cancer Ther; 2020 Sep; 19(9):1922-1929. PubMed ID: 32606015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Near-Infrared Imaging with Second-Window Indocyanine Green in Newly Diagnosed High-Grade Gliomas Predicts Gadolinium Enhancement on Postoperative Magnetic Resonance Imaging.
    Cho SS; Salinas R; De Ravin E; Teng CW; Li C; Abdullah KG; Buch L; Hussain J; Ahmed F; Dorsey J; Mohan S; Brem S; Singhal S; Lee JYK
    Mol Imaging Biol; 2020 Oct; 22(5):1427-1437. PubMed ID: 31712948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.
    Barbagallo GMV; Certo F; Di Gregorio S; Maione M; Garozzo M; Peschillo S; Altieri R
    Neurosurg Focus; 2021 Jan; 50(1):E20. PubMed ID: 33386001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
    Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
    J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.